Licensing opportunity
Researchers at Lausanne University have developed a new gene delivery system which they say offers increased specificity, efficiency and safety in gene therapy.
The invention relates to new DNA molecules that have insulator or boundary properties, and their use for the construction of vectors that enable controlled genetic expression.
Another aspect of the invention concerns the treatment of patients diagnosed with a genetic disease by administering such new vectors.
Additional information is available upon request (Ref.IDF05/07).
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
